|
FFVC TENANT COMPANIES
Accurate Electronics, Inc.
Arclight Wireless, Inc.
Cromoz, Inc.
Device Solutions LLC
Discover Technologies, Inc.
Endacea, Inc.
Endls Optics
Envigen Pharmaceuticals, Inc.
First Flight Venture Center
FirstString Research
Galaxy Diagnostics, Inc.
HomeHealthNetwork
Inanovate
Instrumentation Associates
Jenken Biosciences, Inc.
Learning Machines, Inc.
LearnVC.com
Mechanical Specialties Contractors, Inc.
MediBeam Health Monitors/Turrett Labs
NanIO BioSciences
Network Development Group
OC3 Entertainment
Parrish Brian Partners, Inc.
PDSolutions, Inc.
PHARSTAT, Inc.
Ribonomics, Inc.
Ridge Diagnostics
Sirga Advanced Biopharma
SnowFin, LLC
Spratt Financial
TechVerse
Turrett Labs/Medibeam Health Monitors
Wyrick Robbins Yates & Ponton LLP
Zoe Health Care System
Zumatek, Inc.
Accurate Electronics, Inc.
George Daniel - President (919) 558-2200
Accurate Electronics, Inc. designs and manufactures antennas for in-building wireless communications such as 802.11 or Wi- Fi applications as well as mobile radio applications that include cell phones and Bluetooth devices.
http://www.accuratron.com
Arclight Wireless, Inc.
Creighton Moss - President (919) 354-1025
No information available at this time.
Cromoz, Inc.
Iffat Allam - President (919) 354-1071
Cromoz is a manufacturer of non toxic water soluble Carbon Nanotubes and Carbon Carbon Dots for target drug delivery and for and as fluorescent probes for imaging.
Our brightly photo luminescent Carbon Quantum Dots are targeted to revolutionize the cellular imaging requirement by replacing fluorescent dyes and other heavy metal based quantum dots in both invitro and in vivo critical to early disease detection and rapid screening.
Our mission is to consistently deliver high quality carbon nanomaterials and carbon nano-enabled products for biomedical applications.
We are currently developing carbon nano particle based filters for water purification and desalination.
http://www.cromoz.com
Device Solutions LLC
Bob Witter - COO (919) 619-6659
Device Solutions provides platform, feature, and application feasibility studies, specification development, project management, development and testing for handheld mobile devices. We have the capability to support all or any portion of the design and development cycle. Device Solutions specializes in design and development of Java and Brew applications, M2M cellular module integration projects, and device performance, acceptance, and certification testing.
http://www.device-solutions.com
Discover Technologies, Inc.
Matthew Bennett - President (919) 767-0620
Discover Technologies, Inc. develops and manufactures electroactive polymer (EAP) based electromechanical sensors and actuators for the aerospace and biomedical industries. These materials are soft, lightweight, and durable. As actuators, these EAP devices can generate larger strains (1-10%) at lower applied voltages (1-5V) than other smart material systems. As sensors, Discover Technologies' EAPs offer very high sensitivity while being conformable and durable. The company's focus is on the development of sensors and actuators for applications that make use of the unique advantages of EAPs. Commercialization of this technology will be accomplished through industrial partnerships with device and systems manufacturers.
http://www.discover-technologies.com
Endacea, Inc.
Don Wilson - President, CEO & General Counsel (919) 406-1888, X-1400
Constance Neely Wilson, M.D. - Founder and Chief Scientific Officer (919) 406-1888, X-1402
Endacea, Inc. is developing a series of proprietary A1 adenosine receptor (AR) antagonists as drugs for inflammatory diseases, including asthma and sepsis, and an endotoxin assay as a biomarker for patients at risk of sepsis. The Company has demonstrated therapeutic efficacy for its lead compound, L-97-1, in an allergic rabbit model of asthma and in two rat models of sepsis, including post exposure adjunctive (to antibiotics) treatment of pneumonic plague (severe Gram-negative sepsis). Endacea is also developing L-97-1 as a better oral diuretic for patients with acute decompensated heart failure and renal impairment. The Company has a growing patent estate that includes 15 issued U.S. patents, 11 pending U.S. patent applications, and 18 issued or allowed international patents.
http://www.endacea.com
Endls Optics
Nimmi Ramamujam - President (919) 433-1687
Endls Optics, Inc. was founded in 2006 by Duke University Professor Nimmi Ramanujam. Endls Optics is a private company located in the Research Triangle Park, NC. The company develops novel optical diagnostic tools to aid in the clinical diagnosis and treatment of cancer. Endls has a strong team with expertise in medicine, clinical studies, biophysics, biomedical and optical engineering and administration. They work in a number of different areas of biophotonics, ranging from the development of mathematical models to describe the basic physics of light propagation in turbid media (tissue) to engineering new optical technologies for clinical diagnosis of breast cancer and intraoperative assessment of tumor margins.
Envigen Pharmaceuticals, Inc.
Anil Sharma - President and CEO (919) 520-6565
No information available at present time.
First Flight Venture Center
John C. Draper - President (919) 990-8558
First Flight Venture Center is a business incubator providing facilities and services for technology-based companies in Research Triangle Park.
http://www.ffvcnc.org
FirstString Research
Gautam Ghatnekar - President (919) 354-1080
FirstString Research is a biotech company focused on developing a peptide-based technology platform for scar prevention and regenerative healing.
http://www.firststringresearch.com
Galaxy Diagnostics, Inc.
Amanda Elam - President (919) 354-1055
Galaxy Diagnostics, Inc. is a new diagnostics company based on proprietary technologies from the College of Veterinary Medicine at North Carolina State University. This company provides a diagnostic service to physicians and veterinarians to test patients for evidence of Bartonella infection. Galaxy’s advanced diagnostic for Bartonella involves the use of a patented growth media combined with state-of-the-art molecular-based bacterial DNA detection. The results are highly accurate and significantly more sensitive than any other available method for detecting infection by Bartonella.
http://www.galaxydx.com
HomeHealthNetwork
Harry Bailes - President (919) 740-0965
No information available at present time.
Inanovate
David Ure - President & CEO (617) 610-1712
Inanovate's mission is to make accurate cancer screening available and
affordable to everyone. To achieve this mission, Inanovate combines
proprietary nano-scale surface technologies, protein screening procedures, and protein biomarker content, with cutting edge expertise and facilities; to create advanced biochip systems for handling and working with proteins.
In addition to the development of clinical diagnostic systems, Inanovate
offers a range of pre-clinical products and services designed to make
protein biochip based research more accurate, more reliable and more cost effective. Our offerings include the i-Slide protein micro-array substrate platform-the leading surfaces in the world for handling and working with proteins; unique and powerful biomarker screening and validation procedures; and a wide variety of protein micro-array services including protein printing/arraying, and assay development.
http://www.inanovate.com
Instrumentation Associates
Ronald Berliner - President (919) 765-0034
Instrumentation Associates provides software, equipment, design and fabrication services for instruments used in neutron scattering research.
Jenken Biosciences, Inc.
J. Barry Buzogany - President & CEO (919) 765-0032
Jenken Biosciences is a biopharmaceutical company dedicated to the discovery and development of a new class of small molecules for the treatment of organ damage associated with inflammation, as well as related diseases. Other indications for its lead compound, or one of its analogs, include liver cancer and arthritis.
http://www.jenkenbio.com
Learning Machines, Inc.
Jim McLean - Chief Executive Officer (919) 485-4403
Learning Machines, Inc. (LMI) provides application software and software-related services to the education industry.
http://www.learningmachines.com
LearnVC.com
Jeff Boardman - President and Co-founder (919) 627-1008
LearnVC – provides a web-based application for entrepreneurs and investors to model investments into startups. Free educational material is provided on LearnVC.com with an invite-only beta program for the full modeling software.
http://LearnVC.com
Mechanical Specialties Contractors, Inc.
Tony Sample - President (919) 767-0631
MSC develops, designs, and installs high purity piping work for the microelectronics industry in North Carolina.
MediBeam Health Monitors/Turrett Labs
Vijay Velu - President (919) 765-0055
MediBeam Health Monitors provides advanced telemedicine products and services to a worldwide audience. Our research and development facilities now focus on next generation embedded systems for in-home health care monitoring. Our services include home health monitoring systems and complete training services for urban and rural communities that wish to incorporate a telemedicine program linking physicians and nurse practitioners with government emergency services, assisted living communities and remote residential areas.
NanIO BioSciences
Cindy Clark - CEO (919) 354-1052
NanIO Biosciences, Inc., based in Research Triangle Park, NC, is developing a paradigm-changing cancer nanotechnology-based theranostic that will simultaneously deliver a long-acting tumor imaging technology with targeted chemotherapy.
Network Development Group
Richard Weeks - President (919) 990-9070
NDG is a team of experienced network engineers with software development and project management skills. Each network engineer has over 10 years of planning, operational and troubleshooting experience. Our goal is to provide IT services and create software products that assist organizations with day-to-day operations of networking.
OC3 Entertainment
Doug Perkowski - CEO (919) 767-0626
OC3 Entertainment provides facial animation technology, which serves as the gateway for human-computer and human-human interaction in 3D environments. The video game industry is currently on the cutting edge of computer graphics, and OC3 Entertainment works with some of the world's most respected game developers, publishers and middleware providers. More serious applications for facial animation technology include machinima, 3D communication systems, simulated training environments, and web-based customer relationship management applications.
Parrish Brian Partners, Inc.
Parrish B. Ketchmark - CEO (919) 765-0022
Parrish Brian Partners, Inc. provides investment capital, corporate finance and business development expertise to both early stage (micro cap) and middle market (small cap) private and public companies. We seek investment opportunities in which we can meaningfully contribute, as a working partner, to the advancement of the business enterprise, resulting in significantly increased shareholder value.
PDSolutions, Inc.
Jennifer Dixon - CEO (919) 638-8000
PDS is the largest privately-held Consultation, Training & Development firm specializing in Early Childhood Education and Childcare in North Carolina. Though sometimes we work alongside the county-ran Resource & Referral Agencies and we share common goals in many ways, we are an entirely separate and unique organization.
PDS is proudly owned, operated and only employs experienced and talented Early Childhood Professionals. Our methods are tried and true, and enjoy an unheard of customer satisfaction rating. We provide MANY extraordinary programs, including rating Scale Prep (100% success rating four years in a row), a large variety of workshops, administration consulting, Director & Assistant Director Training, Compliance Checks & Maintenance Programs, and so much more!
http://www.pdsolutionsnc.com/
PHARSTAT, Inc.
Larry Fang - President (919) 423-2042
PHARSTAT, Inc. is a small CRO that provides statistical consulting and programming support/services for clinical trials. The company has senior staff members with an average of over 10 years experience in the pharmaceutical industry.
Ribonomics, Inc.
Shinobu Kitamura - Vice President, Business Development (919) 767-0625
Ribonomics is pioneering the discovery of novel therapeutic targets and biomarkers through interrogation of RNA regulatory networks. The Company’s patented RIP-Chip technology is the only high-throughput approach for direct elucidation and analysis of these networks, whose importance has become increasingly clear with the growing appreciation for RNAi and the role of RNA utilization in determining normal and disease outcomes. RIP-Chip involves isolating RNA-protein complexes from a cell or tissue and identifying the co-localized mRNAs, regulatory RNAs (e.g. microRNAs) and protein components. Because these cellular components are co-localized within the cell, RIP-Chip provides direct evidence for functional relationships between these molecules and enables identification of RNA regulatory networks, including microRNA target sets, and novel components of cellular pathways. The functional relationship inherent in RIP-Chip data represents a significant advantage over other ‘omic’ strategies. Ribonomics has amassed the worlds largest collection of RIP-Chip grade antibodies and is utilizing this resource in disease models of diabetes and cancer for identification of novel pathway components that represent potential therapeutic targets and biomarkers.
Ridge Diagnostics
John Bilello - Chief Scientific Officer (919) 354-1044
Ridge Diagnostics is a neurodiagnostic company nearing the commercialization of its proprietary first-in-class blood test for Major Depressive Disorder (MDD). Based upon its proprietary Human Biomarker Library and Biomarker Hyper-Map technology (BHMÔ) platform, and supported by its new CLIA-certified clinical laboratory. Ridge Diagnostics researches, develops, and commercializes multi-variant biological marker assays and diagnostic algorithms to diagnose and monitor treatment for MDD and other neuropsychiatric disorders." Our BHMÔ approach incorporates multiple markers from distinct human biological pathways. These biological markers are mapped onto a multi-dimensional hyperspace model to create the hyperspace vectors that construct and define the patterns which can aid in classifying patients. A consistent change in these patterns is also used to evaluate the efficacy of antidepressant therapy. This approach has already received strong endorsement and support from thought leaders in leading medical schools and in the psychiatric medical community. Ridge is a member of the prestigious Massachusetts General Hospital Clinical Trials Network Initiative (CTNI). The MGH CTNI is involved with planning and executing clinical trials for most of the major pharmaceutical companies. Ridge expects that its breakthrough blood test will significantly advance the ability to effectively select, monitor and optimize depression treatment.
http://www.RidgeDx.com
Sirga Advanced Biopharma
Cindy Clark - President (919) 354-1007
Sirga Advanced Biopharma, Inc. (SirgaAB) is an early-stage drug discovery and development company, focusing on small molecule drugs to treat HIV, other infectious diseases, and autoimmune disorders. SirgaAB is focusing on fighting disease through a novel mechanism to block ribonucleic acid (RNA) function at the cellular level. Because of their central role in all of biology, RNAs are difficult for the pathogens to alter, thereby minimizing the possibility of drug resistance. SirgaAB is focusing on diseases where drug resistance is a significant problem. The Company is a spin-out of NC State University (NCSU), and was formed in 2007.
SnowFin, LLC
Steven Giles - President (919) 767-0633
SnowFin provides inexpensive, outsourced IT services to businesses with less than 75 employees. With SnowFin, you get the IT department your business has always needed.
http://www.snowfin.com
Spratt Financial
Joseph W. Spratt - President (919) 765-0019
Financial advisors to start-up and emerging growth companies in matters concerning fundraising, capital structure, financial reporting systems and business valuation. With more than 20 years experience in industry and financial services; we can help you identify opportunities, formulate achievable business plans and grow your business efficiently.
TechVerse
Dr. Ashok Damle - President (919) 454-8461
Techverse, Inc. is involved in research and development of advanced energy concepts with focus in hydrogen generation, storage, and utilization in PEM fuel cells. Techverse, Inc. offers consulting services in process design and model simulations as well as technical services with laboratory experimental studies for process and energy efficiency improvements.
Turrett Labs/Medibeam Health Monitors
Vijay Velu - President (919) 765-0055
See MediBeam Health Monitors
Wyrick Robbins Yates & Ponton LLP
J. Christopher Lynch - Attorney 919-781-4000
Founded in 1979, Wyrick Robbins is an entrepreneurial law firm with a focus on growth-oriented businesses. We handle sophisticated financial and corporate transactions and complex commercial litigation as well as other legal needs of dynamic companies. We also serve as trusted advisers to founders, investors, directors and management. Our clients range from startup and early-stage companies to established growth companies. Over the past three decades, our firm has grown to become one of the largest law firms based in the Research Triangle Park area. One important reason for our growth has been the value proposition we offer clients--high-quality legal services that deliver practical solutions--all at a reasonable cost.
http://www.wyrick.com/
Zoe Health Care System
Bright Winner - President (919) 765-0023
Favor Winner - Vice President (919) 765-0023
Zoe Health Care provides compassionate and high quality, non-medical home care by trained and bonded staff for those in need of personal care, companionship or housekeeping services. We provide service for both short and long term periods based on your loved one’s needs.
http://www.zoehealthcare.com
Zumatek, Inc.
Randolph McKinley - CEO (919) 225-3965
Zumatek, Inc. is a medical imaging company specializing in the development of leading edge 3D dedicated imaging technologies for enhanced lesion detection. Researchers at Duke University Medical Center founded ZumaTek for the purpose of commercializing a platform of innovative, patient friendly dedicated breast scanners designed to detect the presence of breast cancer much earlier than current technologies on the market. With the patient lying comfortably in the prone position, the scanners identify tumors in a patient's uncompressed breast by using either (a) nuclear medicine - to
detect chemical changes in breast cells that are associated with malignancy; (b) low dose x-rays to collect CT images of the breast and provide a road-map pinpointing the suspected malignancy in 3D; or (c) a combination of both technologies in a dual modality scan providing both functional and structural imaging simultaneously. The device has undergone extensive feasibility testing with patient trials planned for 2010. Advanced prototypes are available.
http://www.zumatek.com
|
